Novogene

Chinese genome sequencing company Novogene has filed a lawsuit against the United States over its designation as a Chinese military company, according to Reuters. The case challenges Washington's decision to list the firm as affiliated with China's military, a label that can restrict business and investment ties. The dispute highlights ongoing tensions between the US and Chinese tech and biotech firms.